IBA Press Releases
Provision Contracts With IBA To Install Proton Therapy System
Read it in : French - English
WILEX and IBA report on follow up meeting with the FDA on further steps in the development of REDECTANE®
Read it in : English
Trading Update - 3rd Quarter 2011
Read it in : French - English
The Polish Academy of Sciences Selects IBA’s Proton Therapy Technology for the Second Time
Read it in : French - English
Willis-Knighton Cancer Center in Shreveport, Louisiana, to install First Ultra-Compact Proton Therapy Solution from IBA
Read it in : French - English
2011 First Half Results: Strong Improvement of the Operating Cash Flow - IBA Strenghtens its Leadership in Proton Therapy
Read it in : French - English
IBA PARTNER PET NET EXPANDS ITS RADIOPHARMACEUTICALS NETWORK IN GERMANY THROUGH COLLABORATION WITH UNIVERSITY HOSPITAL OF MUNICH
Read it in : English
IBA celebrates its 25th anniversary and adopts from today onwards its vision for 2020 of personalized medicine
Read it in : French - English
WILEX and IBA report on the Pre-BLA Meeting with the FDA and the next steps in the REDECTANE® approval process
Read it in : English
IBA patented its dual proton source for PET Cyclotrons
Read it in : English
Trading update - first quarter 2011
Read it in : French - English
IBA Takes a 25 % stake in PET Net Germany and reinforces global PET radiopharmaceuticals network
Read it in : French - English
IBA signs a contract with Skandionkliniken for the installation of Scandinavia first dedicated proton therapy center
Read it in : French - English
2010 Annual Results - Net Income Growth - Payment of a Dividend of 15 euro cents per share - Record Order Book
Read it in : French - English
IBA continues to reinforce its leadership in Proton Therapy
Read it in : French - English
IBA selected for a new Proton Therapy Center in Dresden, Germany
Read it in : French - English
IBA halts negotiations with a financial consortium regarding the transfer of a majority holding in Bioassays
Read it in : French - English
